期刊文献+

鼻咽癌组织中EGFR和nm23基因表达与预后关系研究 被引量:3

Prognostic value of the expression of EGFR and nm23 in nasopharyngeal carcinoma
原文传递
导出
摘要 目的探讨表皮生长因子受体(EGFR)和转移抑制基因(nm23)表达与鼻咽癌(NPC)患者预后的相关性。方法回顾分析本院2003--2006年放疗前行鼻咽活检且资料完整的127例经病理证实的鼻咽癌患者,所有患者均采用6MVX线调强放疗联合顺铂+氟尿嘧啶方案化疗。采用免疫组化链霉素抗生物素蛋白-过氧化物酶法(SP)检测活检标本中EGFR和nm23表达,随访5年并分析其与预后关系。结果EGFR和nm23在鼻咽癌活检标本中的阳性表达率分别为80.3%和47.2%。nm23不同表达与鼻咽癌患者发生远处转移相关(X^2=7.03,P=0.008)。全组患者5年局部控制率、总生存率(0s),无瘤生存率(DFS)分别为58.3%、53.5%、46.5%。EGFR阴性者5年0s,DFS比阳性者高(∥=8.23,P=0.004;X^2=5.25,P=0.022),nm23阳性者5年OS,DFS均比阴性者高(X^2=15.68,P=0.000;X^2=14.85,P=0.000)。Cox回归模型多因素分析显示分期、EGFR及nm23鞑均可作为判断鼻咽癌患者预后的因素(X^2=23.03、18.33、39.92,P=0.000、0.000、0.000)。结论EGFR和nm23表达与鼻咽癌患者预后密切相关,可作为预测鼻咽癌患者的预后因素。 Objective To evaluate the prognostic value of the expression of epidermal growth factor receptor (EGFR) and nm23 in patients with nasopharyngeal carcinoma (NPC). Methods From 2003 to 2006, 127 NPC patients who had undergone biopsy before radiotherapy were reviewed retrospectively. All patients received intensity-modulated radiotherapy using 6 MV X-rays combined with platinum-based chemotherapy. Immunohistochemistry SP method was adopted to detect the expression of EGFR and nm23 in NPC biopsy specimens . The relationship between the expression of EGFR and nm23 and survival was analyzed. Results The positive rate of EGFR and nm23 were 80. 3% and 47.2% respectively. The nm23 expression was correlated with distant metastasis ( X^2 = 7. 03, P = 0. 008 ). The 5-year estimated local control, over-all survival (OS) and disease-free survival (DFS) were 58.3% ,53.5% and 46. 5%. Patients with negative expression of EGFR had a significantly better 5-year OS, DFS (X^2 = 8.23, P = 0. 004 ;X^2= 5. 25,P--0. 022) than those with positive expression. Patients with positive expression of rim23 had a significantly higher 5-year OS (X^2= 15.68,P = 0. 000) and DFS (X^2 = 14. 85, P = 0. 000) than those with negative expression. The clinical stage, EGFR and nm23 expression were independent prognostic factors shown by Cox proportional hazard model (X^2 = 23.03, 18.33, 39.92, P = 0. 000, 0. 000, 0. 000). Conclusions The EFGR and nm23 expression were correlated with the prognosis in NPC patients.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2011年第2期87-90,共4页 Chinese Journal of Radiation Oncology
关键词 鼻咽肿瘤 表皮生长因子受体 NM23 预后 Nasopharyngeal neoplasms Epidermal growth factor receptor nm23 Prognosis
  • 相关文献

参考文献15

  • 1Cojocariu OM, Huguet F, Lefevre M, et al. Prognosis and predictive factors in head and neck cancers. Bull Cancer, 2009, 96:369-678.
  • 2Wu M, Li X, Li X, et al. Signaling Transduetion network mediated by tumor suppressor/susceptibility genes in NPC. Curr Genomics ,2009,10:216-222.
  • 3Sarkis SA, Abdullah BH, Abdul Majeed BA, et al. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis. Head Neck Oncol,2010,25:13.
  • 4Thariat J, Milas L, Ang KK, et al. Integrating radiotherapy with EGFR antagonisis and other molecular therapeutics for the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys, 2007,69:974-984.
  • 5Laskin JJ, Sandier AB. Epidermal growth factor receptor: a promising target in solid tumors. J Cancer Treat Rev, 2004, 30 : 1 - 17.
  • 6Leong JL, Lob KS, Putti TC, et al. Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Larygscope, 2004,114: 153-157.
  • 7Garden AS, Milas L, Ang KK, et al. Combination of radiotherapy with EGFR antagonists for head and neck carcinoma. Int J Clin Oncol, 2007,12:99-110.
  • 8Cripps C, Winquist E, Devries MC,et al. Epidermal growth factor receptor targeted therapy in stages Ⅲ and IV head and neck cancer. CmT 0ncol,2010,17:37-48.
  • 9Taheri-Kadkhoda Z, Magnusson B, Svensson M,et aL Expression modes and clinical manifestations of latent membrane protein 1, Ki-67, cyclin-B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma. Head Neck, 2009, 31: 482 -492.
  • 10Ang KK, Berkey BA, Tu XY, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res, 2002,11:7350-7356.

二级参考文献18

  • 1刘泰福,徐国镇.全国鼻咽癌会议纪要[J].中华放射肿瘤学杂志,1992,0(4):5-10. 被引量:132
  • 2郑天荣,谢佐福,林贤东,张竟时,陆莉莉.nm23蛋白在人鼻咽癌中的表达[J].中华病理学杂志,1997,26(2):118-118. 被引量:14
  • 3Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapotosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinoma. Cancer Res, 1998, 58:1808-1911.
  • 4Steeg PS, Bevilacqua G, Kopper L, et al, Evidence for a novel gene associated with cow humor metastatic potential. J Natl Cancer Inst, 1988,80:200-204.
  • 5Baba H, Urano T, Okada K, et al. Two isotypes of murine nm23/nucleotide diphosphate Kinase, nm23-H1 and nm23-H2, are involved in metastatic suppression of murine melanoma line. Cancer Res, 1995, 55:1977-1980.
  • 6Ambrosini G, Adidac, Actieri DC. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 1997,3: 917-921.
  • 7Asra M, Marine M, Tish NH, et al. Human survivin is negatively regulated by wide-type p53 and participates in P53-dependent apoptotic pathway. Oncogene,2002,21:2613-2022.
  • 8Tao ZH, Tomas O, Zheng QG, et al. Evidence that APC regalates survivin expression. Cancer Res,2001,61: 8664-8667.
  • 9Jennifer T,Janesz R,Capucine S,et al. Marked induction of the IAP family aniapoptotic proteins survivin XYAP by VEGF in vascular endothelial cells. Biochemical and Biophysical Research. Communication, 1999,264: 781-788.
  • 10Adida C,Crotty PL, McGrath J,et al. Developmently regulated expression of the novel cancer antiapoptasis gene survivin in human and mouse proliferation. Am J Pahol, 1998,152:43-46.

共引文献6

同被引文献33

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部